tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
23d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
1M ago
NRx Pharmaceuticals (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
1M ago
NRx Pharmaceuticals files $150M mixed securities shelf
PremiumThe FlyNRx Pharmaceuticals files $150M mixed securities shelf
2M ago
NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
2M ago
NRX Pharmaceuticals Submits FDA Application for NRX-100
Premium
Company Announcements
NRX Pharmaceuticals Submits FDA Application for NRX-100
2M ago
NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
2M ago
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition
2M ago
NRX Pharmaceuticals Announces $7.8M Debt Financing Deal
Premium
Company Announcements
NRX Pharmaceuticals Announces $7.8M Debt Financing Deal
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100